RJ's large buy has been the most recent factor driving the stock period.

Is now a good time to buy? I think so if you can stand a 10-20% swing down that may or may not come. As a long term play this stock has a lot of potential, especially if they can start getting roche milestone payments toward the end of the year.

The large cash position right now will allow them to carry out Chemophase trials without a partner and further develop the other enzymes they have in the pipeline.

I view this stock as a PDLI but with better management. Also it doesn't hurt that RJ has a good amount of confidence in this stock.

So yes I would get into this stock right now...but only with say 1/2 or 1/3 of what you are planning to invest...Through the summer this stock may drift down and you can pick up more...or it may spike up on news...either way hold off some powder to see what might develop.

-pokerden